vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and GSI TECHNOLOGY INC (GSIT). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.1M, roughly 1.5× GSI TECHNOLOGY INC). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -234.3%, a 184.6% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 12.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 8.6%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
FHTX vs GSIT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $9.2M | $6.1M |
| Net Profit | $-21.7M | $-3.0M |
| Gross Margin | — | 52.7% |
| Operating Margin | -258.2% | -113.7% |
| Net Margin | -234.3% | -49.7% |
| Revenue YoY | 223.8% | 12.2% |
| Net Profit YoY | -11.1% | 25.0% |
| EPS (diluted) | $-0.35 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $6.1M | ||
| Q3 25 | $8.2M | $6.4M | ||
| Q2 25 | $7.6M | $6.3M | ||
| Q1 25 | $6.0M | $5.9M | ||
| Q4 24 | $2.9M | $5.4M | ||
| Q3 24 | $7.8M | $4.5M | ||
| Q2 24 | $6.9M | $4.7M | ||
| Q1 24 | $5.0M | $5.2M |
| Q4 25 | $-21.7M | $-3.0M | ||
| Q3 25 | $-15.8M | $-3.2M | ||
| Q2 25 | $-17.9M | $-2.2M | ||
| Q1 25 | $-18.8M | $-2.2M | ||
| Q4 24 | $-19.5M | $-4.0M | ||
| Q3 24 | $-19.1M | $-5.5M | ||
| Q2 24 | $-23.0M | $1.1M | ||
| Q1 24 | $-25.0M | $-4.3M |
| Q4 25 | — | 52.7% | ||
| Q3 25 | — | 54.8% | ||
| Q2 25 | — | 58.1% | ||
| Q1 25 | — | 56.1% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 46.3% | ||
| Q1 24 | — | 51.6% |
| Q4 25 | -258.2% | -113.7% | ||
| Q3 25 | -226.9% | -49.5% | ||
| Q2 25 | -279.2% | -34.6% | ||
| Q1 25 | -385.0% | -38.7% | ||
| Q4 24 | -840.5% | -74.9% | ||
| Q3 24 | -305.5% | -122.7% | ||
| Q2 24 | -386.6% | 23.1% | ||
| Q1 24 | -558.3% | -87.6% |
| Q4 25 | -234.3% | -49.7% | ||
| Q3 25 | -194.4% | -49.4% | ||
| Q2 25 | -237.3% | -35.3% | ||
| Q1 25 | -316.4% | -37.9% | ||
| Q4 24 | -682.9% | -74.4% | ||
| Q3 24 | -244.9% | -120.0% | ||
| Q2 24 | -333.6% | 23.1% | ||
| Q1 24 | -495.4% | -83.9% |
| Q4 25 | $-0.35 | $-0.09 | ||
| Q3 25 | $-0.25 | $-0.11 | ||
| Q2 25 | $-0.28 | $-0.08 | ||
| Q1 25 | $-0.30 | $-0.09 | ||
| Q4 24 | $-0.23 | $-0.16 | ||
| Q3 24 | $-0.31 | $-0.21 | ||
| Q2 24 | $-0.45 | $0.04 | ||
| Q1 24 | $-0.59 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $70.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $83.6M |
| Total Assets | $198.1M | $98.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $70.7M | ||
| Q3 25 | $89.3M | $25.3M | ||
| Q2 25 | $72.6M | $22.7M | ||
| Q1 25 | $61.0M | $13.4M | ||
| Q4 24 | $55.5M | $15.1M | ||
| Q3 24 | $57.7M | $18.4M | ||
| Q2 24 | $138.9M | $21.8M | ||
| Q1 24 | $79.3M | $14.4M |
| Q4 25 | $-108.5M | $83.6M | ||
| Q3 25 | $-89.7M | $38.6M | ||
| Q2 25 | $-76.7M | $37.4M | ||
| Q1 25 | $-61.7M | $28.2M | ||
| Q4 24 | $-45.5M | $29.9M | ||
| Q3 24 | $-28.3M | $33.3M | ||
| Q2 24 | $-14.3M | $38.0M | ||
| Q1 24 | $-97.5M | $36.0M |
| Q4 25 | $198.1M | $98.5M | ||
| Q3 25 | $205.0M | $52.0M | ||
| Q2 25 | $226.2M | $50.5M | ||
| Q1 25 | $258.7M | $43.3M | ||
| Q4 24 | $284.0M | $44.1M | ||
| Q3 24 | $308.4M | $47.4M | ||
| Q2 24 | $328.6M | $52.3M | ||
| Q1 24 | $255.0M | $42.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-7.9M |
| Free Cash FlowOCF − Capex | — | $-8.2M |
| FCF MarginFCF / Revenue | — | -134.4% |
| Capex IntensityCapex / Revenue | 0.0% | 4.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-7.9M | ||
| Q3 25 | $-18.9M | $-887.0K | ||
| Q2 25 | $-21.0M | $-1.7M | ||
| Q1 25 | $-24.0M | $-1.7M | ||
| Q4 24 | $-24.5M | $-3.6M | ||
| Q3 24 | $-21.0M | $-3.5M | ||
| Q2 24 | $-25.5M | $-4.3M | ||
| Q1 24 | $-29.3M | $-7.1M |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-906.0K | ||
| Q2 25 | $-21.0M | $-1.7M | ||
| Q1 25 | $-24.0M | $-1.7M | ||
| Q4 24 | $-25.0M | $-3.6M | ||
| Q3 24 | $-21.3M | $-3.5M | ||
| Q2 24 | $-25.6M | $-4.3M | ||
| Q1 24 | $-29.4M | $-7.2M |
| Q4 25 | — | -134.4% | ||
| Q3 25 | — | -14.1% | ||
| Q2 25 | -278.2% | -27.6% | ||
| Q1 25 | -403.2% | -28.3% | ||
| Q4 24 | -875.3% | -66.1% | ||
| Q3 24 | -273.0% | -76.6% | ||
| Q2 24 | -371.0% | -92.0% | ||
| Q1 24 | -583.1% | -139.0% |
| Q4 25 | 0.0% | 4.9% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 16.8% | 0.1% | ||
| Q3 24 | 4.0% | 0.1% | ||
| Q2 24 | 0.2% | 0.7% | ||
| Q1 24 | 2.0% | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.96× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |